Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 8Active not recruiting 3Unknown 1

Sponsor Class

OTHER 12NIH 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1

Conditions

Leukemia, Hairy Cell 1Colorectal Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 188Magnetic Resonance Spectroscopy 143Biopsy 116Nivolumab 39X-Rays 29Immunoglobulin G 29Disulfides 29Radiation 28Carboplatin 27atezolizumab 25Taxes 25Paclitaxel 25pembrolizumab 23Radiotherapy 23Ipilimumab 23CTLA-4 Antigen 23olaparib 22Cyclophosphamide 22Cisplatin 21Platinum 20Gemcitabine 20Doxorubicin 20Bevacizumab 201,2-diaminocyclohexaneplatinum II citrate 20Phantoms, Imaging 19Vincristine 17trametinib 16cabozantinib 15Rituximab 15ibrutinib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × NIH × Aspirin × Clear all
NCT02965703 2026-05-28

Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
81 enrolled 13 charts
Gastrointestinal

Colorectal Neoplasms

NCT03805932 2026-05-19

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting
18 enrolled 15 charts
Other hematologic neoplasm

Leukemia, Hairy Cell

NCT02521285 2026-04-29

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

National Cancer Institute (NCI)

Phase 2 Active not recruiting
21 enrolled 35 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡